- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
OutcomesMaternal Dyslipidemia Raises Pregnancy Risks; Diet May Improve Outcomes: Suggests Study

A recent review highlights that maternal dyslipidemia significantly elevates risks for preeclampsia and gestational diabetes, yet targeted dietary interventions—such as increasing omega-3s and fiber—can effectively optimize lipid profiles and improve perinatal outcomes, as published in Indian Obstetrics & Gynaecology in July-Sept 2025.
While pregnancy induces physiological metabolic shifts to support fetal growth, pathological dyslipidemia—characterized by abnormal levels of triglycerides and cholesterol—affects approximately 30% of expectant mothers in India; identifying this clinical gap, Mr. Mohd Faisal Khan from Jamia Millia Islamia and colleagues aimed to consolidate evidence on managing these lipid variations through dietary interventions to improve maternal-fetal health.
Therefore, the systematic review analyzed observational studies, randomized controlled trials, and meta-analyses from 2016 onwards, prioritizing global and Indian data to evaluate the impact of lipid metabolism on pregnancy complications while identifying the urgent need for standardized reference values.
Key clinical findings of this study include:
Triglyceride Thresholds: Elevated triglycerides exceeding 250 mg/dL in late pregnancy are independently associated with a higher incidence of GDM, preeclampsia, and Large-for-Gestational-Age (LGA) infants.
Preterm Birth Risk: High total cholesterol and triglycerides correlate with a 15-20% increased risk of preterm delivery and Fetal Growth Restriction (FGR), particularly in South Asian populations.
HDL-C Protection: Low High-Density Lipoprotein Cholesterol (HDL-C) levels significantly increase the risk of macrosomia, whereas higher levels demonstrate a protective effect against metabolic complications.
Long-term Cardiovascular Impact: Mothers with persistent dyslipidemia face a 20-30% higher risk of postpartum metabolic syndrome and cardiovascular disease a decade later.
Dietary Efficacy: Replacing refined carbohydrates with complex carbohydrates and increasing soluble fiber to 10-30 g/day can lower low-density lipoprotein cholesterol (LDL-C) by 7-10%.
The results suggest that early screening and proactive dietary management, such as reducing saturated fats to under 7% of daily calories, are vital to prevent adverse outcomes like macrosomia and preterm birth, especially given that Indian studies show a 10% higher incidence of low birth weight in dyslipidaemic pregnancies.
Thus, the study concludes clinicians should prioritize early first-trimester lipid profiling to predict potential complications and implement non-pharmacological nutritional counseling as a primary management strategy.
Although current diagnosis is limited by the lack of pregnancy-specific lipid reference ranges, future high-quality randomized controlled trials and longitudinal studies are essential to fully quantify long-term cardiovascular risks for both mother and child.
Reference
Khan MF, Khurana A, Sharma KA, Nigam A, Alam S, Mustafa S, Dev K. Effect of maternal lipid profile on perinatal outcome: clinical insights and dietary interventions. Indian Obstet Gynaecol. 2025;15(3):29-35.

